Tocilizumab-Induced Sweet Syndrome in a Patient With Polymyalgia Rheumatica
Keywords:
tocilizumab, tocilizumab-induced Sweet syndrome, drug-induced Sweet syndrome, neutrophilic dermatosisReferences
1. Baroni A, Piccolo V, Russo T, Cozzolino D, Mascolo M, Chessa MA. Norfloxacin-induced subacute cutaneous lupus with erythema multiforme-like lesions: the enigma of the Rowell syndrome. J DtschDermatolGes 2014;12:1039-42.
2. Walker D C, Cohen P R. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome. J Am Acad Dermatol 1996;34:918-23.
2. Walker D C, Cohen P R. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome. J Am Acad Dermatol 1996;34:918-23.
Published
2019-12-31
Issue
Section
Letter
License
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
1.
Filippi F, Chessa MA, Patrizi A, Baraldi C, Ferrara F, Bardazzi F. Tocilizumab-Induced Sweet Syndrome in a Patient With Polymyalgia Rheumatica . Dermatol Pract Concept. Published online December 31, 2019:e2020019. doi:10.5826/dpc.1001a19

